Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cytyc’s Higher Bid For Vision Systems Puts Ball Back In Ventana’s Court

This article was originally published in The Gray Sheet

Executive Summary

Cytyc's proposed $374 mil. offer for cancer and infectious disease detection equipment maker Vision Systems Sept. 13 could start a bidding war for the Australian company

You may also be interested in...



Danaher Beats Out Cytyc, Ventana In Battle For Vision Systems

Cytyc and Ventana are bowing out of a bidding war for cancer and infectious disease detection equipment maker Vision Systems, which says it prefers a richer offer valued at $520 mil. from diversified industrial firm Danaher

Danaher Beats Out Cytyc, Ventana In Battle For Vision Systems

Cytyc and Ventana are bowing out of a bidding war for cancer and infectious disease detection equipment maker Vision Systems, which says it prefers a richer offer valued at $520 mil. from diversified industrial firm Danaher

Vision Systems bidding war continues

Bidding competition for anatomical pathology instrument maker Vision Systems could gain a third contender in Danaher. The diversified manufacturer of microscopic imaging, measurement and analysis tools is considering making an offer for Vision after acknowledging preliminary discussions Sept. 26. Ventana offered $346 mil. for the firm Aug. 13, after which Cytyc proposed a $374 mil. deal Sept. 13. On Sept. 29, Cytyc increased its bid to $517 mil., to "underscore" its "commitment" to completing a transaction in the wake of "increased interest from potential acquirors." Ventana has acquired a 10.2% stake in Vision Systems through open market purchases of 22 mil. shares. Meanwhile, Cytyc has "commitments for 13.9%" of Vision's fully diluted shares (1"The Gray Sheet" Sept. 18, 2006, p. 6)...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023987

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel